GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
838
c/retatrutide·posted 28 days ago by u/signe_villalobos

[Discussion] the TRIUMPH advice in here is 2 years out of date

Discussion Slow Clap ×8

Posting this as a discussion rather than a claim: the TRIUMPH advice in here is 2 years out of date.

Figures up front so nobody has to dig: 2 years.

Sent a vial to Medutest out of curiosity. Result was 98.4% against a claimed 97.5%, which is the first independent number I had seen for this compound anywhere.

The thing that surprised me was how much of the discussion here is inference rather than measurement.

Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.

1,101 up / 263 down81% upvoted43 commentsid 1vp4w01 Jul 2026

43 comments

11 in this archive, depth 2

best — the order this archive was captured in

u/hugo_pires98 points·27 days ago

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

replysharereportpermalink
u/bastian_ekstrom59 points·27 days ago

That is body weight change, not fat mass. The trials report the first and people quote it as the second.

replysharereportpermalink
load more comments (1) →
u/placebo_arm_pam96 points·27 days ago

The standing caveat, written out properly because it keeps getting compressed into a footnote.

Nothing containing this compound is approved by any regulator. Research-use-only material is not approved for human use. That is not a legal formality on this board — it is why there is so little independent data, why the escalation schedules people post are invented, and why nobody here can answer a dosing question.

What this board can usefully do is read the published trials carefully, log independent purity results, and be honest about how thin the evidence base is. Everything else belongs somewhere with a clinician in it.

replysharereportpermalink
u/source_or_silence45 points·27 days ago

The standing caveat, written out properly because it keeps getting compressed into a footnote.

Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.

replysharereportpermalink
u/yannick_salinas55 points·28 days ago

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer.

replysharereportpermalink
u/devils_advocate_d47 points·27 days ago

What is the source for that figure — the published paper or a summary of it?

replysharereportpermalink
u/andres_sorensen28 points·27 days ago·edited

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

replysharereportpermalink
u/signe_villalobosOP12 points·27 days ago

Has anyone posted an independent test on this compound recently?

replysharereportpermalink
u/source_or_silence9 points·27 days ago

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

replysharereportpermalink
u/signe_villalobosOP14 points·27 days ago

not approved anywhere, which is the single most important fact in this board

replysharereportpermalink
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.